We previously reported greater GABA A receptor-mediated tonic currents in D 2 ϩ striatopallidal than D 1 ϩ striatonigral medium spiny neurons (MSNs) are mediated by ␣5-subunit-containing receptors. Here, we used whole-cell recordings in slices from bacterial artificial chromosome transgenic mice to investigate the link between subunit composition, phosphorylation, and dopamine receptor activation. Whole-cell recordings in slices from ␦-subunit knock-out mice demonstrate that while MSNs in wild-type mice do express ␦-subunitcontaining receptors, this receptor subtype is not responsible for tonic conductance observed in the acute slice preparation. We assessed the contribution of the ␤1-and ␤3-subunits expressed in MSNs by their sensitivity to etomidate, an agonist selective for ␤2-or ␤3-subunit-containing GABA A receptors. Although etomidate produced substantial tonic current in D 2 ϩ neurons, there was no effect in D 1 ϩ neurons. However, with internal PKA application or dopamine modulation, D 1 ϩ neurons expressed tonic conductance and responded to etomidate application. Our results suggest that distinct phosphorylation of ␤3-subunits may cause larger tonic current in D 2 ϩ striatopallidal MSNs, and proper intracellular conditions can reveal tonic current in D 1 ϩ cells.
Introduction
The majority of neurons in the dorsal striatum, a major nucleus of the basal ganglia, are GABAergic projections called medium spiny neurons (MSNs) that express either dopamine D 1 receptors (D 1 ϩ) in the striatonigral pathway or dopamine D 2 receptors (D 2 ϩ) in the stratopallidal pathway (Gerfen et al., 1990) . Although these two cell types have similar basic physiological properties (Venance and Glowinski, 2003; Day et al., 2006; Taverna et al., 2008) , we recently reported that D 2 ϩ MSNs have greater GABA A receptor-mediated tonic conductance than D 1 ϩ MSNs (Ade et al., 2008) . The subunits responsible for tonic conductance are fairly well established in other brain regions (Glykys and Mody, 2007) , but those subunits that mediate tonic conductance in the striatum remain elusive. D 1 and D 2 receptors are G-protein-coupled receptors (GPCRs) and regulate protein kinase A (PKA) phosphorylation via differing second messenger cascade systems. D 1 receptors activate PKA, whereas D 2 agonists inactivate PKA (Chen et al., 2006) through G s /G olf , and G i/o proteins, respectively (Stoof and Kebabian, 1984) . PKA activity is essential to the physiological states of GABA A receptors as ␤1-and ␤3-subunits are substrates for PKA-mediated phosphorylation (Moss et al., 1992; McDonald et al., 1998; Flores-Hernandez et al., 2000; Kittler et al., 2005) . However, the response to phosphorylation is subunitspecific, and ␤1-subunit phosphorylation reduces, whereas ␤3-subunit phosphorylation enhances GABAergic currents (McDonald et al., 1998; Nusser et al., 1999; Flores-Hernandez et al., 2000) . Immunostaining studies show that all ␤-subunits are expressed in the rat striatum (Fritschy and Mohler, 1995; Pirker et al., 2000; Schwarzer et al., 2001) , but single-cell PCR results suggest that MSNs do not express the ␤2-subunit (Flores-Hernandez et al., 2000) . Etomidate, a general anesthetic selective for the ␤2/␤3 GABA A subunits (Hill-Venning et al., 1997) , should selectively enhance currents at ␤3-subunit-containing receptors in MSNs and thus is an ideal tool to detect the presence of this subunit in MSNs. Therefore, all GABA A receptors in the striatum, both synaptic and extrasynaptic, may potentially be modulated by dopamine and its effects on PKA phosphorylation.
Tonic currents are of particular interest as they control excitability and are differentially expressed in D 1 ϩ and D 2 ϩ neurons. Inhibitory tonic conductance of the dorsal striatum controls the striatonigral and striatopallidal outputs for movement initiation and control. Since Parkinson's disease symptoms result from imbalances in these two pathways (Mallet et al., 2006) , striatal tonic conductance may offer a potential therapeutic role in ameliorating physiological manifestations of Parkinsonian symptoms.
In this study, we further investigated the mechanisms underlying tonic conductance in striatal MSNs, and we explored the interactions between dopamine agonists, PKA phosphorylation, and tonic inhibition in MSNs. Our results show that differences in tonic currents are attributable to differential subunit expression patterns and basal phosphorylation rates. Tonic conductance in D 2 ϩ MSNs is attributable to extrasynaptic and basally phosphorylated ␤3-subunit-containing GABA A receptors, but D 1 ϩ MSNs also exhibit tonic conductances via phosphorylated ␤3-subunits with internal PKA application or D 1 receptor stimulation. Our studies also suggest that dopamine exhibits influence on cell excitability through these mechanisms.
Materials and Methods
Animals. Bacterial artificial chromosome (BAC) D 2 -enhanced green fluorescent protein (EGFP) mice (Gong et al., 2003) (provided by David Lovinger, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD) were crossed with C57BL/6 mice. Slices were prepared from postnatal day 15-23 male and female mice as in Ade et al. (2008) , unless otherwise noted. MSNs were classified as being either dopamine D 2 receptor positive (D 2 ϩ) or negative by their expression of EGFP. Because previous studies have demonstrated that MSNs express either dopamine D 1 or D 2 receptors (Gerfen et al., 1990; Day et al., 2006) , MSNs negative for EGFP in the BAC D 2 EGFP mice were presumed to be D 1 ϩ and those expressing EGFP as D 2 ϩ. ␦-subunit knock-out mice (provided by Dr. Gregg Homanics, Department of Anesthesiology, University of Pittsburgh, Pittsburgh, PA) were genotyped with Southern blot as described in Mihalek et al. (1999) .
Slice preparation. Mice were killed by decapitation in agreement with the guidelines of the American Veterinary Medical Association Panel on Euthanasia and the Georgetown University Animal Care and Use Committee. The whole brain was removed and placed in an ice-cold slicing solution containing (in mM) 85 NaCl, 2.5 KCl, 1 CaCl 2 , 4 MgCl 2 , 1 NaH 2 PO 4 , 25 NaHCO 3 , 25 glucose, 75 sucrose (all from Sigma). Corticostriatal coronal slices (250 m) were prepared using a Vibratome 3000 Plus Sectioning System (Vibratome) and were incubated in slicing solution at 32°C for 30 min. Slices recovered for 30 min at 32°C in artificial CSF (aCSF) containing (in mM) 124 NaCl, 4.5 KCl, 1.2 Na 2 HPO 4 , 26 NaHCO 3 , 2 CaCl 2 , 1 MgCl 2 , and 10 dextrose at 305 mOsm. During experiments, slices were submerged and continuously perfused (2-3 ml/ min) with aCSF at room temperature, 22-24°C, unless otherwise noted. All solutions were maintained at pH 7.4 by continuous bubbling with 95% O 2 , 5% CO 2 .
Slices were visualized under an upright microscope (E600FN; Nikon) equipped with Nomarski optics and an electrically insulated 60ϫ waterimmersion objective with a long working distance (2 mm) and high numerical aperture (1.0). Recording electrodes were pulled on a vertical pipette puller from borosilicate glass capillaries (Wiretrol II; Drummond) and filled with Cs Cl-based internal recording solution (CsCl internal) containing (in mM) 145 CsCl, 10 HEPES, 5 ATP.Mg, 0.2 GT-P.NA, and 10 EGTA, adjusted to pH 7.2 with CsOH. In K-gluconatebased internal solutions (K-gluconate internal), CsCl was replaced with equimolar K-gluconate. In some experiments, cell impermeable protein phosphorylation modulators were supplemented in the internal solution. A bovine catalytic subunit PKA (50 -75 g/ml; Sigma) and PKA inhibitory peptide (PKI; 20 M; Sigma H2N-TYADFIASGRTGRRNAIamide) were initially prepared in water and maintained at Ϫ20°C. The PKA stock solution was used within 3 d of reconstitution according to manufacturer specifications.
Whole-cell recordings. Single and dual voltage-clamp recordings were performed using the whole-cell configuration of the patch-clamp technique at a pipette voltage of Ϫ60 mV using the Axopatch 200B and 1D amplifiers (Molecular Devices). Access resistance was monitored during the recordings, and experiments with Ͼ20% change were discarded. The baseline membrane potential for current-clamp recordings was set at Ϫ70 mV before each series of current step injection protocols. Rheobase current was defined as the first current step, within a series of increasing 20 pA steps, that elicited an action potential.
Stock solutions of bicuculline methobromide (BMR), tetrodotoxin (TTX), 4, 5, 6, (THIP) , SKF-81297, quinpirole, sulpiride, SCH 23390, and GABA (all from Sigma) were prepared in water. Etomidate (Sigma) was dissolved in dimethylsulfoxide (Ͻ0.0001% final concentration). All stock solutions were diluted to the desired concentration in aCSF and applied locally through a Y tube (Murase et al., 1989 ) modified for optimal solution exchange in brain slices (Hevers and Luddens, 2002) .
Currents were filtered at 2 kHz with a low-pass Bessel filter and digitized at 5-10 kHz using a personal computer equipped with Digidata 1322A data acquisition board and pCLAMP9 software (both from Molecular Devices). Off-line data analysis, curve fitting, and figure preparation were performed with Clampfit 9 software (Molecular Devices). Spontaneous and miniature IPSCs (sIPSCs and mIPSCs) were identified using a semiautomated threshold based minidetection software (Mini Analysis; Synaptosoft) and were visually confirmed as in Ade et al. (2008) . Briefly, IPSC averages were based on more than 60 events, and the decay kinetics were determined using double exponential curve fittings and reported as weighted time constants (tau). All detected events were used for event frequency analysis, but superimposing events were eliminated for the amplitude, rise time, and decay kinetic analysis. Tonic current measurements were made as in Ade et al. (2008) . Briefly, an all-points histogram was plotted for a 10 s period immediately before and during BMR application. Tonic currents are represented as the change in baseline amplitude. When PKA or PKI was included in the internal solution, events were analyzed at least 4 min after break-in to allow the peptide to function and equilibrate with the internal components of the cell. Statistical significance was determined using the two-tailed Student's t test (unpaired when comparing two populations of cells and paired when comparing results within the same cell). All values are expressed as mean Ϯ SEM. In all figures, *p Ͻ 0.05, **p Ͻ 0.005, and ***p Ͻ 0.0005.
Human embryonic kidney 293 cells and transfection. Human embryonic kidney 293 (HEK 293) cells (American Type Culture Collection; CRL1573) were grown in minimal essential medium (Invitrogen), supplemented with 10% fetal bovine serum, 100 units/ml penicillin, and 100 units/ml streptomycin (all from Invitrogen) in a 5% CO 2 incubator at 36°C. Growing cells were dispersed with trypsin and seeded at ϳ2 ϫ 10 5 cells/35 mm dish in 2 ml of culture medium on 12 mm glass coverslips coated with poly-D-lysine. The cells were transfected with rat GABA A receptor subunit cDNAs, because of their high homology to mouse receptors, and EGFP using calcium phosphate precipitation. The following plasmid combinations were used: ␣2␤1␥2, ␣2␤3␥2, ␣5␤1␥2, and ␣5␤3␥2 (all a gift from Peter Seeburg, University of Heidelberg, Heidelberg, Germany) at a ratio of 1:1:4. Mixed plasmids (5 g total) were added to the dish containing 2 ml culture medium for 8 -12 h at which point the media was refreshed. The cells were used for electrophysiological recordings 2-3 d after transfection.
Results

GABA A receptors in MSNs
Our previous study suggested that the major differences in tonic current between D 1 ϩ and D 2 ϩ MSNs lies in the presence of ␣5-containing receptors in D 2 ϩ neurons (Ade et al., 2008) . Additionally, both D 1 ϩ and D 2 ϩ MSNs had similar sensitivity to low doses of THIP, a ␦-subunitcontaining GABA A receptor superagonist (Brown et al., 2002) , suggesting that both MSN subtypes express the ␦-subunit. To support these results, we performed whole-cell recordings in MSNs in striatal slices prepared from ␦-subunitϪ/Ϫ mice. We observed a BMR-sensitive current in a subset of the cells (Fig. 1 A) , and a similar scatter in tonic current expression by distinct MSN subtypes in ␦Ϫ/Ϫ and BAC D 2 EGFP mice ( Fig. 1 B) , supporting the hypothesis that although the ␦-subunit is present in MSNs, it is not responsible for tonic current in the age range investigated. However, as shown in Figure 1C , MSNs from these mice lost responsiveness to low doses of THIP as previously reported in hippocampal neurons from ␦Ϫ/Ϫ mice (Glykys et al., 2008) .
Because the magnitude of tonic current was not different between BAC D 2 EGFP mice and the ␦Ϫ/Ϫ mouse, we hypothesized that tonic current in D 2 ϩ cells is mediated by ␣5␤x␥2 receptors. Both ␤1-and ␤3-subunits are targets for PKA phosphorylation, and their presence may have robust effects on tonic current. To study the relative ␤-subunit expression and function in striatal D 2 ϩ and D 1 ϩ cells, we used etomidate (3 M), a general anesthetic specific for the ␤2/␤3-subunits of the GABA A receptor (Belelli et al., 1996; Herd et al., 2008) . The ␤-subunit selectivity of etomidate was initially demonstrated in recombinant systems with ␣1␤1␥2-and ␣1␤3␥2-subunit combinations (Slany et al., 1995; Sanna et al., 1997) . Subsequently, the differential effects of etomidate between ␤1-and ␤2-subunits were shown to be maintained in receptors that contained the ␣1-, ␣2-, ␣3-, or ␣6-subunits (Hill-Venning et al., 1997) . In addition, a study using ␣5Ϫ/Ϫ mice demonstrated that etomidate mediates amnestic but not sedative-hypnotic effects by selectively activating the tonic, not phasic, GABA A currents (Cheng et al., 2006) . Because the specificity of this drug has not been tested in recombinant systems that include the ␣5-subunit, we investigated the efficacy of etomidate in HEK 293 cells transfected with striatally relevant ( etomidate's direct effects on striatally relevant GABA A receptors (␣2␤1␥2, n ϭ 6; ␣2␤3␥2, n ϭ 10; ␣5␤1␥2, n ϭ 5; ␣5␤3␥2, n ϭ 7). D, Summary of etomidate's potentiating effects on GABA currents evoked by EC10 concentrations of GABA on each receptor type (␣2␤1␥2, n ϭ 4; ␣2␤3␥2, n ϭ 5; ␣5␤1␥2, n ϭ 13; ␣5␤3␥2, n ϭ 6).
In these cells, we tested both direct activation of the recombinant GABA A receptors and modulation of GABA responses with etomidate. The general anesthetic produced significant current in cells expressing ␤3-containing GABA A receptors but failed to directly activate those cells transfected with the ␤1-subunit (Fig.  2 A, B) , regardless of the ␣-subunit. In each cell studied, we tested the response to multiple GABA concentrations and compared them to a saturating dose of GABA (3 mM) to select the EC10 used to compare etomidate's direct effects with GABA potentiation. Figure 2 , A and B, shows examples of direct and potentiating effects in transfected cells with ␣2␤1␥2, ␣2␤3␥2, ␣5␤1␥2, and ␣5␤3␥2 receptors. The summary of the results obtained with different ␣-subunits tested are shown in Figure 2 , C and D. Etomidate robustly potentiated GABA current produced by ␤3-containing receptors and had a slight potentiating effect on those produced by ␤1-containing receptors when expressed with the ␣2-subunit. However, etomidate produced similar potentiating responses in ␤1-and ␤3-containing receptors when combined with the ␣5-subunit. We concluded from these experiments that the direct agonist actions of etomidate are selective for receptors containing ␤3-subunits but not those containing ␤1-subunits.
Interestingly, although the maximal GABA response was comparable between the two ␣2-containing recombinant receptors, the response to 3 M GABA was 7 Ϯ 3% (n ϭ 5) of the maximal response in ␣2␤1␥2 cells and 31 Ϯ 7% (n ϭ 10) of the maximal response in ␣2␤3␥2 cells ( p Ͻ 0.05). This differential affinity for GABA was not apparent in the ␣5-containing transfected receptors for any concentrations of GABA (data not shown). However, these receptors had higher sensitivity to GABA than ␣2-containing receptors (1 M GABA; ␣5␤1␥2, 25 Ϯ 4% of maximal response, n ϭ 18; ␣5␤3␥2, 17 Ϯ 2% of maximal response, n ϭ 23).
Because striatal MSNs presumably do not express the ␤2-subunit (FloresHernandez et al., 2000), etomidate's effects in these neurons are an indication of the presence of ␤3-subunit. In Figure 3A , we show individual traces from a D 2 ϩ and a D 1 ϩ MSN, and as summarized in Figure  3C (left), etomidate produced substantial tonic current in the D 2 ϩ neurons, whereas the response in D 1 ϩ MSNs was significantly smaller and did not differ from baseline. As GABAergic interneurons may express the ␤2-subunit (Yan and Surmeier, 1997), we repeated these experiments in 0.5 M TTX to block interneuron activity, given that spontaneous activity of these neurons contributes to tonic current in MSNs (Ade et al., 2008) . In TTX, etomidate produced 34 Ϯ 6 pA (n ϭ 16) of current in D 2 ϩ MSNs and just 10 Ϯ 2 pA (n ϭ 13) in D 1 ϩ MSNs ( p Ͻ 0.05). Tonic current in MSNs is produced by unknown concentrations of ambient GABA. Thus, etomidate effects could be attributable to a combination of direct activation and potentiation of GABA channels. However, ambient GABA is at such low concentrations that any potentiation effect will be minimal. Thus, if the direct activation predominates, it implies that ␤3-subunit expression is greater in D 2 ϩ than D 1 ϩ MSN.
As D 1 ϩ MSNs do not display endogenous tonic current, we compared the effects of the anesthetic on exogenously applied GABA to determine the potentiating action of etomidate in both cell types. Figure 3B shows examples of the etomidate potentia- (Fig. 3C, right) .
To assess the etomidate response on synaptic GABA A receptors, we investigated changes in mIPSCs in the two MSN subtypes. Using CsCl internal solution to enhance detection of mIPSCs from distal locations, basic properties of mIPSCs did not differ between MSN subtypes as reported previously (Ade et al., 2008) . 
PKA regulates MSN tonic current
Although differential extrasynaptic expression of the ␤3-subunit may yield increased tonic conductance in the D 2 ϩ MSNs, PKA phosphorylation may be an important mediator and increase the number of tonically active GABA channels with distinct subunit combinations. To determine the effect of PKA on D 2 ϩ and D 1 ϩ MSN tonic conductances, we added the catalytic subunit of PKA (50 -75 g/ml) to the CsCl internal solution to measure the effects of postsynaptic PKA modulation without affecting presynaptic release probability. Figure 5A shows that with inclusion of the PKA catalytic subunit, a D 1 ϩ neuron had an increased BMR-sensitive tonic current, whereas the tonic current was smaller in a D 2 ϩ MSN. Under conditions that promote PKA phosphorylation, the D 1 ϩ neurons express tonic current, suggesting that phosphorylation is an important regulator of tonic conductance in striatal MSNs. Figure 5C shows that internal PKA application did not alter the decay times of mIPSCs for D 2 ϩ or D 1 ϩ neurons.
Based on our hypothesis that tonic current is mediated by ␤3-containing receptors, we investigated the effect of etomidate on the magnitude of tonic current in D 2 ϩ and D 1 ϩ neurons with internal PKA application. In a simultaneous dual recording of a D 2 ϩ and a D 1 ϩ MSN with internal PKA application (Fig. 5D) , etomidate uncovered tonic current in the D 1 ϩ MSN, but etomidate responses in D 2 ϩ neurons were slightly smaller compared with control conditions (Fig. 5 D, E) . Again, these experiments were repeated in TTX (0.5 M) to block interneuron activity, and the same observations were made: internal PKA application increased the D 1 ϩ etomidate response (21 Ϯ 4.4 pA, n ϭ 10, p ϭ 0.07), whereas the D 2 ϩ response decreased (26 Ϯ 5.1 pA, n ϭ 8, p Ͻ 0.05). Etomidate responses did not differ between the D 2 ϩ and the D 1 ϩ MSNs with internal PKA application, indicating that the two MSN subtypes have a similar population of ␤3-containing receptors. Because etomidate revealed a tonic current in D 1 ϩ cells with internal PKA application, it appears that a phosphorylated ␤3-subunit is responsible, in part, for GABA A tonic conductance in both MSN subtypes.
To verify that endogenous PKA phosphorylation is involved in mediating D 2 ϩ MSN tonic current, we supplemented the PKI (20 M) in the internal solution and measured the changes in tonic current compared with control conditions. PKI attenuated the D 2 ϩ MSN tonic current (5.0 Ϯ 1.0 pA, n ϭ 7 compared with 26 Ϯ 3.6 pA, n ϭ 14, p Ͻ 0.0005) while not affecting the tonic current in D 1 ϩ MSNs (4.8 Ϯ 1.9 pA, n ϭ 4 compared with 3.4 Ϯ 0.4 pA, n ϭ 11, p ϭ 0.3). PKI had no discernible effects on synaptic receptors as sIPSC decay, amplitude, or frequency did not change (D 2 ϩ, n ϭ 13; D 1 ϩ, n ϭ 4). Dopamine modulation of GABA currents D 1 and D 2 GPCRs contribute to the phosphorylation cascade in MSNs. Although D 1 activation promotes phosphorylation, the D 2 receptor acts to reduce PKA activity and increase activity of protein phosphatase 1 through DARPP-32 (Stoof and Kebabian, 1984) . Thus, dopamine release in the striatum should promote PKA activity in D 1 ϩ MSNs while inhibiting PKA activity in D 2 ϩ MSNs. Therefore, we sought to determine basal dopamine levels in our slice preparation as free dopamine will affect our system in drastically different ways. In whole-cell recordings from four D 2 ϩ MSNs, the D 2 antagonist sulpiride (2 M) did not affect tonic or phasic currents (data not shown). Likewise, recordings from D 1 ϩ MSNs in SCH 23390 (10 M) also did not affect tonic or phasic currents (n ϭ 5). These results suggest that dopamine is not present in our recording conditions in young mice or that it is present in such low concentrations that it does not activate D 1 and D 2 receptors. Because modulating internal phosphorylation altered the tonic GABA currents in MSNs, we sought to determine if dopamine also affects the phosphorylation cascade, yielding altered GABA receptor function in D 2 ϩ and D 1 ϩ neurons. First, we applied the D 2 -like agonist quinpirole (10 M) to both D 2 ϩ and D 1 ϩ MSN followed by application of BMR (25 M) after recording for ϳ5 min to allow the full effects of the agonist and GPCR (Price et al., 1999 ). Figure 6 A shows recordings from individual D 2 ϩ and D 1 ϩ MSNs with quinpirole (10 M) application. The D 2 -like agonist decreased the D 2 ϩ BMR-sensitive tonic current after 5 min of application without significantly affecting the tonic current in the D 1 ϩ MSN. In a dual recording, SKF-81297 (10 M) induced a BMR-sensitive tonic current in the D 1 ϩ MSN but also slightly decreased the D 2 ϩ tonic current as well (Fig. 6 B) . As summarized in Figure  6C , D 2 receptor stimulation, and probable blockade of PKA phosphorylation, decreased tonic currents in D 2 ϩ MSNs, whereas D 1 receptor stimulation, and promotion of PKA phosphorylation, induced tonic currents in D 1 ϩ MSNs. These drugs were specific for their associated dopamine receptor as application did not alter tonic currents in the opposing cell type (Fig. 6C) . Therefore, GABA tonic conductance in both D 2 ϩ and D 1 ϩ MSNs is under dopamine control, presumably via a PKA phosphorylation cascade that affects ␤3-containing GABA A receptors.
Because temperature may affect phosphorylation function and rates, we repeated these experiments with the D 2 and D 1 receptor agonists at more physiological temperatures (32°C). As reported previously (Ade et al., 2008) , tonic current was still significantly larger in D 2 ϩ than D 1 ϩ MSNs in these conditions. At this temperature, application of quinpirole (10 M) on D 2 ϩ neurons decreased BMR-sensitive tonic current to 38 Ϯ 19% (n ϭ 3) of control, whereas BMR sensitive tonic current was increased by SKF-81297 in D 1 ϩ neurons to 184 Ϯ 34% (n ϭ 3) of control. At room temperature, quinpirole reduced D 2 ϩ tonic current to 39 Ϯ 10% (n ϭ 5) of control, and SKF-81297 increased D 1 ϩ tonic current to 274 Ϯ 32% (n ϭ 4) of control. Therefore, phosphorylation cascades remain intact at more physiological temperatures and elicit similar effects as at room temperature.
To confirm that the D 1 ϩ MSN tonic current seen with SKF-81297 application is attributable to extrasynaptic ␤3-containing GABA A receptors, we applied etomidate (3 M) in these conditions. Figure 6 E shows currents from a D 1 ϩ neuron with etomidate application before and during coapplication with SKF-81297. When coapplied with the D 1 agonist, etomidate produced a significantly greater response than when it was applied alone (etomidate, 8.3 Ϯ 2.2 pA; SKF-81297 plus etomidate, 16 Ϯ 4.2 pA; n ϭ 4; p Ͻ 0.05). These data support the hypothesis that tonic current in D 1 ϩ cells induced by SKF-81297 is mediated through ␤3-containing receptors.
It has recently been suggested that GABA tonic currents are not present in D 2 ϩ or D 1 ϩ MSNs in older mice (Gertler et al., 2008) , suggesting that dopamine and phosphorylation may play different roles in adult mice. We tested for tonic currents in older mice and investigated their modulation through dopamine receptors. We observed BMR-sensitive tonic currents in both D 2 ϩ and D 1 ϩ MSN in animals between p33 and p37, although the magnitude was reversed compared with younger animals. compared with younger animals), whereas D 1 ϩ MSNs averaged 18.3 Ϯ 1.2 pA tonic current (n ϭ 6; p Ͻ 0.05 compared with younger animals), suggesting that dopaminergic tone may change through development. Thus, we investigated the effects of specific dopamine receptor antagonists sulpiride (2 M) and SCH 23390 (10 M) in D 2 ϩ and D 1 ϩ MSNs from these older animals. With their respective antagonists, tonic current increased to 14.7 Ϯ 1.5 pA in three D 2 ϩ MSNs and 26.4 Ϯ 1.7 pA in four D 1 ϩ MSNs, supporting a change in dopaminergic tone. To determine whether PKA phosphorylation also mediates tonic current in older animals, we supplemented PKI into the CsCl internal and saw a significant reduction in D 1 ϩ tonic current (6 Ϯ 1.8 pA, n ϭ 4; p Ͻ 0.0005) in these older mice compared with normal internal conditions. Internal PKI application did not change the tonic current in four D 2 ϩ cells from older animals.
To determine dopamine's modulatory role on phasic GABA A receptors, we analyzed sIPSCs before and after agonist application (TTX was not applied so as to not block tonic current). Although both quinpirole and SKF-81297 tended to increase the decay time in the D 2 ϩ and D 1 ϩ MSN, respectively, the results were not significant (Fig. 6 D) . In combination with the etomidate results, these data suggest that D 2 ϩ and D 1 ϩ MSN synaptic receptor populations include both ␤1-and ␤3-subunit containing receptors. Because we show here that dopamine modulates GABA tonic currents and our previous study showed that GABA tonic currents control cell excitability (Ade et al., 2008) , we tested dopamine's effects on rheobase and firing frequency in MSNs. In a series of current-clamp experiments, we injected increasing depolarizing current steps from a membrane potential of Ϫ70 mV before and after D 2 and D 1 agonist application (Fig. 7 A, B) . As previously reported, D 1 ϩ MSNs had significantly higher rheobase currents than D 2 ϩ MSNs (Ade et al., 2008; Gertler et al., 2008) . Quinpirole (10 M) significantly increased the rheobase and significantly decreased the firing frequency in D 2 ϩ cells (Fig. 7D) . In contrast, no differences in rheobase current or firing frequency were observed with SKF-81297 (10 M) application (Fig. 7 B, C,E) . These results suggest that D 2 ϩ cells are more excitable than D 1 ϩ cells but that D 2 agonists decrease cell excitability, possibly because of their interactions with GABA tonic currents, as shown by the sensitivity of rheobase to BMR.
Etomidate's direct activation of GABA channels in D 2 ϩ but not D 1 ϩ MSNs suggested that tonic conductance in D 2 ϩ neurons was attributable to the presence of extrasynaptic ␤3-containing GABA A receptors. However, internal PKA application and D 1 dopamine receptor stimulation reveals that extrasynaptic ␤3-containing receptors mediate tonic current in D 1 ϩ cells as well. Therefore, D 1 ϩ and D 2 ϩ MSN both have a population of extrasynaptic ␤3-containing receptors that mediate tonic current, but the important difference between the cell types is the phosphorylation state which alters the receptors' function. Thus, we speculated that in our experimental conditions, extrasynaptic receptors in D 1 ϩ MSNs are silent and tonic current in striatal D 2 ϩ MSNs is mediated by basally phosphorylated ␤3-containing receptors. This model is diagrammed with better detail in Figure  8 .
Discussion
Our previous studies revealed differential tonic conductances in D 2 ϩ and D 1 ϩ MSNs that are likely attributable to differential subunit expression (Ade et al., 2008) . We investigated the role of ␣1-, ␣5-, and ␦-subunits and determined the ␣5-subunit to be a likely player in tonic conductance (Ade et al., 2008) . The other two subunits that make up this functional extrasynaptic receptor remained elusive. We further investigated the ␦-subunit because it has been shown to be the primary mediator of tonic GABA current in other brain regions ( al. Glykys et al., 2008) . Although our previous study demonstrated that striatal GABA A receptors contain the ␦-subunit in both MSN subtypes (Ade et al., 2008) , we discovered that the pattern of tonic conductance in a ␦Ϫ/Ϫ mouse matched that from BAC D 2 EGFP mice. This finding is similar to those obtained with ␣1Ϫ/Ϫ mice, suggesting that although ␣1-and ␦-subunits are part of striatal GABA A receptors, they do not underlie the differences observed between D 1 ϩ and D 2 ϩ MSNs (Ade et al., 2008) . We used the general anesthetic etomidate to better ascertain MSN ␤-subunit expression but first verified its efficacy as a modulator and activator of GABA channels using striatally relevant recombinant receptors in HEK 293 cells. We confirmed reported selectivity of etomidate on direct activation of recombinant ␤3-containing GABA A receptors with all ␣-subunits tested (Hill-Venning et al., 1997) . However, etomidate-mediated GABA potentiation was not significantly different between ␣5␤3-and ␣5␤1-containing receptors. This contrasted with results obtained with ␣2␤3-and ␣2␤1-containing receptors, where etomidate's potentiating role retained ␤-subunit specificity. These findings were necessary to interpret etomidate's effects on GABA currents in MSNs in striatal slice preparations. The stronger action of etomidate in D 2 ϩ cells indicated that the ␤3-subunit is more abundant in D 2 ϩ than D 1 ϩ neurons. Low concentrations of exogenous GABA activated current in both D 2 ϩ and D 1 ϩ MSNs, and this current was potentiated by etomidate in both cell types, although the potentiation was significantly greater in D 2 ϩ neurons.
Internal PKA application induced etomidate responses and tonic conductance in D 1 ϩ neurons, suggesting that although D 2 ϩ and D 1 ϩ neurons have similar populations of ␤3-containing receptors, their difference in tonic conductance is attributable to the ␤3-subunit phosphorylation state. Together with previous studies that suggest phosphorylation increases currents through ␤3-subunits (McDonald et al., 1998; Nusser et al., 1999; FloresHernandez et al., 2000) , these data suggest that tonic current in D 1 ϩ MSNs is mediated, in part, through ␤3-containing receptors.
Internal PKA application decreased tonic current in D 2 ϩ cells, implying that GABA receptors on D 2 ϩ neurons also include the ␤1-subunit and/or are basally phosphorylated by an endogenous kinase, either PKA or PKC. Although speculative, too much kinase activity may alter the sta- bility of receptors in the membrane. While we do not know the mechanism that underlies PKA's effect on the decreased D 2 ϩ tonic current, basally phosphorylated ␤3-containing receptors have been found in the hippocampus (Brandon et al., 2000) and cortex (Kumar et al., 2005) , and results from both studies suggested that PKC is responsible for the basal phosphorylation (Kittler and Moss, 2003) . Indeed, internal PKI application decreased D 2 ϩ tonic current, suggesting that D 2 ϩ MSN tonic current is under basal PKA modulation. Further studies, including biochemical analysis, are needed to verify a basally phosphorylated ␤3-subunit in D 2 ϩ neurons. Our results with dopamine antagonists propose that striatal dopamine is not present in our slice preparation in young mice, and therefore both dopamine receptors remain inactive (Lee et al., 2001 ). Activation of D 1 receptors in striatonigral neurons stimulates PKA activity, whereas activation of D 2 receptors in striatopallidal MSNs inhibits PKA activity (Stoof and Kebabian, 1984) . As modeled in Figure 8 , the D 1 receptor agonist SKF-81297 induces tonic currents in D 1 ϩ cells possibly through phosphorylated extrasynaptic ␤3-containing receptors. On the contrary, D 2 ϩ tonic conductance decreases when the D 2 ϩ agonist quinpirole is applied, suggesting a role for dephosphorylated ␤3-containing GABA A receptors. However, quinpirole did not abolish the tonic current, offering a role for ␤1-containing receptors in D 2 ϩ neurons or suggesting that the remaining current is via the ␣5-subunit that mediates tonic current, even without enhanced function through phosphorylated ␤3-subunits. The lack of tonic current in D 1 ϩ cells may also be related to more abundant expression of ␣2␤1-containing receptors, supported by HEK 293 cells that showed higher sensitivity to GABA in ␣2␤3-containing receptors than ␣2␤1-containing receptors. The relative abundance of ␤1-and ␤3-subunits, combined with ␣2-or ␣5-subunits, together with distinct dopamine receptor mediated phosphorylation/dephosphorylation, regulates tonic GABA conductance in striatal MSNs.
Our results with dopamine agonists on tonic current were obtained without TTX and with an intact striatal network that includes several types of GABAergic interneurons as well as cholinergic interneurons (Tepper et al., 2004) , which may contribute to the effects we see with dopamine-selective agonists on the opposing cell type. We cannot exclude that some of the dopamine agonist effects are attributable to a presynaptic mechanism. Because results with dopamine receptor activation and internal PKA application were similar, we suggest that dopamine's effects are primarily postsynaptic and dependent upon PKA activity.
We previously showed that differential extrasynaptic ␣5-subunit function contributes to D 2 ϩ tonic conductance (Ade et al., 2008) . Therefore, D 2 ϩ neurons may have an extrasynaptic population of ␣5␤3-containing receptors. As D 1 ϩ neurons lack the ␣5-subunit, tonic conductance in these neurons is most likely mediated via the phosphorylated ␤3-subunit together with the ␣2-subunit. Although etomidate's potentiating effect was specific for ␣2␤3-containing receptors, the effects did not differ between ␣5␤1-and ␣5␤3-containing receptors. Tonic current is potentiated by etomidate in D 2 ϩ MSNs because they express ␣5␤3-containing receptors. In contrast, ␣2␤1-containing receptors are more abundant than ␣2␤3-containing receptors in D 1 ϩ MSNs, and the potentiating effect of etomidate is smaller than in D 2 ϩ MSNs.
Although etomidate, internal PKA application, and dopamine agonists induced significant changes to D 2 ϩ and D 1 ϩ MSN tonic currents, these actions failed to significantly alter synaptic currents. These results indicate that D 2 ϩ and D 1 ϩ MSNs have similar synaptic receptor populations that include both ␤1-and ␤3-subunits. However, as both ␤1-and ␤3-subunits are regulated by PKA and dopamine, it remains to be clarified why these agents fail to alter IPSCs in MSNs. One possible hypothesis suggests that synaptic receptors are composed of complementary amounts of ␤1-and ␤3-subunits, and therefore their differential regulation by these agents is countered. Previous studies into dopamine's modulatory role on inhibitory transmission found that dopamine does not modulate IPSCs in the rat dorsal striatum, although it does affect IPSCs in the ventral striatum (Nicola and Malenka, 1998) . By exclusively modulating tonic, and not phasic, currents in the dorsal striatum, dopamine may regulate cell excitability.
Dopamine has been shown to modulate cell excitability in several animal models and brain regions through a variety of different mechanisms (Belousov and van den Pol, 1997; Ding and Perkel, 2002; Yasumoto et al., 2002; Perez et al., 2006) . We show that dopamine agonists modulate rheobase current and functionally decrease the cell excitability in D 2 ϩ cells without affecting excitability in D 1 ϩ cells. Dopamine modulates many ion channels in MSNs such as Ca 2ϩ and inward rectifier K ϩ channels (Moyer et al., 2007 Figure 8 . Tonic conductance is mediated through a phosphorylated ␤3-subunit. Under basal conditions (little to no dopamine), D 2 receptors do not activate the G i/o protein to inhibit PKA phosphorylation, and the ␤1-and ␤3-subunits are basally phosphorylated. Because the phosphorylated ␤3-subunit yields increased currents and may be more plentiful than extrasynaptic ␤1-subunits, D 2 ϩ MSN display tonic current. Without dopamine, D 1 receptors do not activate the G s /G olf protein to promote PKA phosphorylation, and the dephosphorylated ␤3-subunits do not mediate increased conductance, resulting in smaller tonic current in the D 1 ϩ than the D 2 ϩ MSN. More abundant ␤1-subunit expression in D 1 ϩ MSNs results in increased current only during GABA application. When stimulated, the D 2 receptor activates the G i/o protein to inhibit PKA activity, dephosphorylating the ␤1/␤3-subunits. A dephosphorylated ␤3-subunit results in smaller tonic currents compared with basal conditions. During D 1 stimulation, the G s /G olf protein activates cAMP and PKA pathways to phosphorylate the ␤3-subunit and increase tonic currents.
the excitability in D 1 ϩ MSNs independently of GABA tonic conductance (Moyer et al., 2007) . Previous results from our lab showed that GABA tonic conductance facilitates MSN cell excitability (Ade et al., 2008) . In the present study, BMR did not change rheobase current in D 2 ϩ cells after quinpirole application, suggesting that changes in cell excitability with quinpirole application are mediated through GABA receptors. We suggest that this modulation of GABA tonic currents may support other mechanisms of dopamine modulation for cell excitability.
It has recently been suggested that GABA tonic currents are not present and do not contribute to the different excitabilities between the two types of MSNs in older mice (Gertler et al., 2008) . In our study, we observed tonic conductance in both cell types from older mice. These opposing results may be explained by experimental conditions like extracellular K ϩ concentrations which may alter ambient GABA concentrations by modulating interneuron activity. Tonic currents in both MSN subtypes from older mice had opposite magnitudes, which were also modulated by PKA. In these mice, the action of specific dopamine receptor antagonists on tonic current suggests a possible role for increased ambient dopamine but will require further investigation.
The results presented here suggest a target for striatal GABAergic tonic conductance in MSNs. We posit that a basally phosphorylated ␤3-subunit is responsible for the D 2 ϩ tonic conductance but show that internal PKA application or D 1 agonist application reveals extrasynaptic ␤3-containing receptors that mediate tonic current in D 1 ϩ cells (Fig. 8) . Because Parkinson's disease symptoms arise from an imbalance between D 1 ϩ striatonigral projection and D 2 ϩ striatopallidal projection outputs (Mallet et al., 2006) , a selective target of tonic conductance in striatonigral or striatopallidal pathways offers potential therapeutic benefits in alleviating debilitating motor control symptoms.
